Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Condition: COVID19 Intervention: Biological: Recombinant SARS-CoV-2 Fusion Protein Vaccine Sponsors: Livzon Pharmaceutical Group Inc.; Guangdong Center for Disease Prevention and Control; Simoon Record Pharma Information Consulting Co., Ltd. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials